<DOC>
	<DOCNO>NCT02282033</DOCNO>
	<brief_summary>The purpose study evaluate safety performance Moderato System implant Moderato pacemaker patient require dual chamber pacemaker , also hypertension , order reduce blood pressure .</brief_summary>
	<brief_title>Safety Performance Study Moderato System</brief_title>
	<detailed_description />
	<mesh_term>Bradycardia</mesh_term>
	<mesh_term>Atrioventricular Block</mesh_term>
	<mesh_term>Coronary Vasospasm</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Subject ≥ 18 year age Subject indicated implantation replacement dual chamber permanent pacemaker lead extraction necessary . Subject stable regimen 2 maximally tolerate antihypertension medication , anticipate able maintain without change 3 month . Subject office systolic blood pressure measurement &gt; 140 mmHg two separate day within one week period prior enrollment , average two measurement ≥150 mmHg Subject know secondary cause HTN Subject history atrial fibrillation Subject ejection fraction &lt; 50 % Subject symptoms heart failure NYHA Class II Subject hypertrophic cardiomyopathy , restrictive cardiomyopathy interventricular septal thickness ≥15 mm Subject dialysis Subject estimate Glomerular Filtration Rate ( GFR ) &lt; 30 ml/min/1.73m2 Subject prior neurological event ( stroke TIA ) carotid artery disease Subject know autonomic dysfunction Subject history clinically significant tachyarrhythmia Subject previous active devicebased treatment hypertension Subject exist implant , pacemaker need replace Subject average Systolic BP &gt; 190 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>